INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.570
-0.030 (-1.88%)
At close: Feb 11, 2026, 4:00 PM EST
1.610
+0.040 (2.55%)
After-hours: Feb 11, 2026, 5:56 PM EST
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $41.74 million as of February 11, 2026. Its market cap has decreased by -76.20% in one year.
Market Cap
41.74M
Enterprise Value
15.08M
1-Year Change
-76.20%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $41.74M, a decrease of -46.37%. That is a compound annual growth rate of -8.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 42.54M | 2.56% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 45.75M |
| Kezar Life Sciences | 45.55M |
| OS Therapies | 44.37M |
| Aligos Therapeutics | 44.18M |
| NextCure | 42.94M |
| CEL-SCI | 42.13M |
| ABVC BioPharma | 41.98M |
| Atossa Therapeutics | 41.51M |